Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Zeymer U, et al. Among authors: neuhaus kl. Eur Heart J. 2004 Feb;25(4):322-8. doi: 10.1016/j.ehj.2003.12.008. Eur Heart J. 2004. PMID: 14984921
Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group.
Zeymer U, von Essen R, Tebbe U, Niederer W, Mäurer W, Vogt A, Neuhaus KL. Zeymer U, et al. Among authors: neuhaus kl. Am J Cardiol. 1995 Nov 15;76(14):997-1001. doi: 10.1016/s0002-9149(99)80283-5. Am J Cardiol. 1995. PMID: 7484879
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
Neuhaus KL, von Essen R, Tebbe U, Jessel A, Heinrichs H, Mäurer W, Döring W, Harmjanz D, Kötter V, Kalhammer E, et al. Neuhaus KL, et al. Circulation. 1994 Oct;90(4):1638-42. doi: 10.1161/01.cir.90.4.1638. Circulation. 1994. PMID: 7923646 Clinical Trial.
Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
Neuhaus KL, von Essen R, Vogt A, Tebbe U, Rustige J, Wagner HJ, Appel KF, Stienen U, König R, Meyer-Sabellek W. Neuhaus KL, et al. J Am Coll Cardiol. 1994 Jul;24(1):55-60. doi: 10.1016/0735-1097(94)90541-x. J Am Coll Cardiol. 1994. PMID: 8006283 Free article. Clinical Trial.
208 results